VistaGen Therapeutics (VTGN) Ownership - Who owns VistaGen Therapeutics?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

343 Allerton Avenue

Phone

+1 650 577-3600

Employees

Web

https://www.vistagen.com

Details

Group

Domestic Stock Funds

Fundamentals

VTGN

Capitalization

87.7M

P/E Ratio

N/A

Risk (Beta)

0.14

Dividend Yield

N/A

Total Cash

108M

Total Cash/Share

4.01

Total Debt

1.99M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.04%

Revenue

971K

ROE

N/A

Book Value

105M

P/B Ratio

0.84

Cash Flow

N/A

Earnings

-0.93

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

27K

Current Ratio

17.77

Current Revenue Per Employee

2048.78

Dividends Per Share - Security

N/A

EBITDA

-37.57M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-51.63

Shares Held By Institutions

55.9M

Shares Outstanding - Current

27.1M

Total Liabilities

8.75M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-36.926

View a ticker or compare two or three

Compare

VTGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VTGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology